UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 220

Sortiert nach

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

Journal of neuro-oncology, 2021-03, Vol.152 (1), p.47-54

2021

Volltextzugriff (PDF)

Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

International journal of clinical oncology, 2021-08, Vol.26 (8), p.1441-1449

2021

Volltextzugriff (PDF)

Learning by teaching technological knowledge: conceptual skill development in Japanese overseas subsidiaries

SN Business & Economics, 2022-08, Vol.2 (9), Article 125

2022

Volltextzugriff (PDF)

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma

Journal of neuro-oncology, 2021-09, Vol.154 (2), p.187-196

2021

Volltextzugriff (PDF)

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

Journal of neuro-oncology, 2020-02, Vol.146 (3), p.451-458

2020

Volltextzugriff (PDF)

Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device

Molecular biology reports, 2021, Vol.48 (1), p.395-403

2021

Volltextzugriff (PDF)

Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

Cancers, 2021-02, Vol.13 (4), p.758

2021

Volltextzugriff (PDF)

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid

Cancers, 2024-02, Vol.16 (5), p.1009

2024

Volltextzugriff (PDF)

A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient

Neuropathology, 2020-02, Vol.40 (1), p.99-103

2020

Volltextzugriff (PDF)

Clinical implications of molecular analysis in diffuse glioma stratification

Brain tumor pathology, 2021-07, Vol.38 (3), p.210-217

2021

Volltextzugriff (PDF)

Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors

Scientific reports, 2020-09, Vol.10 (1), p.16162-16162, Article 16162

2020

Volltextzugriff (PDF)

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3177-3187

2021

Volltextzugriff (PDF)

Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study

World neurosurgery, 2022-03, Vol.159, p.e479-e487

2022

Volltextzugriff (PDF)

A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient

Neuropathology, 2022-06, Vol.42 (3), p.197-203

2022

Volltextzugriff (PDF)

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma

Pharmaceuticals (Basel, Switzerland), 2020-12, Vol.13 (12), p.470

2020

Volltextzugriff (PDF)

CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma

Frontiers in immunology, 2021-06, Vol.12, p.670131-670131

2021

Volltextzugriff (PDF)

Time-of-flight MRA signal intensity predicts the cerebral hemodynamic status after superficial temporal artery to middle cerebral artery anastomosis

Journal of clinical neuroscience, 2019-01, Vol.59, p.124-129

2019

Volltextzugriff (PDF)

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification

Clinical neurology and neurosurgery, 2019-12, Vol.187, p.105556-105556, Article 105556

2019

Volltextzugriff (PDF)

A juvenile case of epilepsy‐associated, isocitrate dehydrogenase wild‐type/histone 3 wild‐type diffuse glioma with a rare BRAF A598T mutation

Neuropathology, 2020-12, Vol.40 (6), p.646-650

2020

Volltextzugriff (PDF)

Pediatric glioblastoma with oligodendroglioma component: Aggressive clinical phenotype with distinct molecular characteristics

Neuropathology, 2013-12, Vol.33 (6), p.652-657

2013

Volltextzugriff (PDF)

The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods

Neuroradiology, 2024-02, Vol.66 (2), p.187-192

2024

Volltextzugriff (PDF)

Correction to: Cortical high‑flow sign on arterial spin labeling: a novel biomarker for IDH‑mutation and 1p/19q‑codeletion status in diffuse gliomas without intense contrast enhancement

Neuroradiology, 2023-11, Vol.65 (11), p.1675-1676

2023

Volltextzugriff (PDF)

Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted

Neuroradiology, 2024-03, Vol.66 (3), p.333-341

2024

Volltextzugriff (PDF)

PATH-28. OUTCOME IMPACT OF THE CDKN2A/B HEMI -ZYGOUS DELETION IN IDH-MUTANT ASTROCYTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v173-v174

2023

Volltextzugriff (PDF)

Surgical outcome in elderly patients with intracranial meningioma

Journal of clinical neuroscience, 2018-10, Vol.56, p.63-66

2018

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNeurologia Medico-Chirurgica

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(208)
Japanisch
(97)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

Learning by teaching technological knowledge: conceptual skill development in Japanese overseas subsidiaries

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device

Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid

A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient

Clinical implications of molecular analysis in diffuse glioma stratification

Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study

A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma

CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma

Time-of-flight MRA signal intensity predicts the cerebral hemodynamic status after superficial temporal artery to middle cerebral artery anastomosis

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification

A juvenile case of epilepsy‐associated, isocitrate dehydrogenase wild‐type/histone 3 wild‐type diffuse glioma with a rare BRAF A598T mutation

Pediatric glioblastoma with oligodendroglioma component: Aggressive clinical phenotype with distinct molecular characteristics

The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods

Correction to: Cortical high‑flow sign on arterial spin labeling: a novel biomarker for IDH‑mutation and 1p/19q‑codeletion status in diffuse gliomas without intense contrast enhancement

Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted

PATH-28. OUTCOME IMPACT OF THE CDKN2A/B HEMI -ZYGOUS DELETION IN IDH-MUTANT ASTROCYTOMA

Surgical outcome in elderly patients with intracranial meningioma

Aktive Filter

Suchergebnisse filtern